BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.27
+0.02 (+1.60%)
As of Aug 8, 10:57 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +3,408.7% upside
Low Target $28.75
Average Target $44.56
High Target $50.07
Current Price $1.27
Current
$1.27
Target
$44.56
$28.75 $44.56 avg $50.07
Scenario Analysis
Bear Case
$28.75
2,163.8%
Low target
Base Case
$44.56
+3,408.7%
Avg target
Bull Case
$50.07
+3,842.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.27
0.0% from high
52-Week Low
$0.56
+128.8% from low
Target vs 52W High
$44.56
+3,408.7% vs high
Next Earnings Report
Aug 11, 2026
1d
tomorrow
EPS Est: $-0.11
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%